Advanced Biomed Inc.
ADVB
$4.95
$0.4910.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 49.15% | 6.80% | 14.16% | -16.68% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.69% | 6.02% | 9.20% | -20.61% | -- |
| Operating Income | -28.69% | -6.02% | -9.20% | 20.61% | -- |
| Income Before Tax | 267.11% | -34.06% | -5.33% | 16.83% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 267.11% | -34.06% | -5.33% | 16.83% | -- |
| Earnings from Discontinued Operations | 56.06% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 244.30% | -48.49% | -17.14% | 7.84% | -- |
| EBIT | -28.69% | -6.02% | -9.20% | 20.61% | -- |
| EBITDA | -48.34% | -12.71% | -13.52% | 28.91% | -- |
| EPS Basic | 230.92% | -43.37% | -14.01% | 8.90% | -- |
| Normalized Basic EPS | 1.30% | -29.11% | -2.30% | 17.92% | -- |
| EPS Diluted | 230.92% | -43.37% | -14.01% | 8.90% | -- |
| Normalized Diluted EPS | 1.30% | -29.11% | -2.30% | 17.92% | -- |
| Average Basic Shares Outstanding | 6.74% | 4.69% | 2.64% | 0.71% | -- |
| Average Diluted Shares Outstanding | 6.74% | 4.69% | 2.64% | 0.71% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |